Europe Moves To Suspend Merck Cholesterol Drug
The European Medicines Agency announced Friday that it had confirmed a recommendation to suspend a cholesterol drug treatment by Merck Sharp & Dohme Ltd. after concluding that the drug's benefits don't...To view the full article, register now.
Already a subscriber? Click here to view full article